GOLDMAN CAPITAL MANAGEMENT INC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN CAPITAL MANAGEMENT INC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q4 2017$235,000
-50.4%
46,000
-45.6%
0.23%
-49.3%
Q3 2017$474,000
-18.1%
84,500
-12.4%
0.45%
-27.0%
Q2 2017$579,000
-40.9%
96,500
-41.2%
0.61%
-34.6%
Q1 2017$979,000
-46.0%
164,190
-37.4%
0.94%
-40.3%
Q4 2016$1,814,000
-66.4%
262,190
-35.8%
1.57%
-63.8%
Q3 2016$5,396,000
+14.5%
408,190
-1.8%
4.34%
+7.0%
Q2 2016$4,714,000
+1.9%
415,690
+4.8%
4.06%
+15.9%
Q1 2016$4,625,000
+1.4%
396,690
+2.2%
3.50%
-1.2%
Q4 2015$4,562,000
+13.6%
387,961
+10.5%
3.54%
+23.7%
Q3 2015$4,015,000
-16.3%
350,961
+32.1%
2.86%
-4.2%
Q2 2015$4,798,000
-19.5%
265,690
-14.2%
2.99%
-14.1%
Q1 2015$5,962,000
+9.9%
309,6900.0%3.48%
+16.3%
Q4 2014$5,423,000
-4.0%
309,690
+0.1%
3.00%
+5.7%
Q3 2014$5,651,000
-19.5%
309,297
+1.5%
2.83%
-18.7%
Q2 2014$7,017,000
-6.0%
304,6900.0%3.48%
-13.9%
Q1 2014$7,468,000
+28.1%
304,690
-2.3%
4.04%
+27.0%
Q4 2013$5,832,000
-14.1%
312,0000.0%3.18%
-29.0%
Q3 2013$6,789,000
+17.5%
312,000
-9.0%
4.48%
+36.0%
Q2 2013$5,780,000343,0003.30%
Other shareholders
TRINITY BIOTECH PLC shareholders Q3 2023
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders